Sigma Planning Corp Night Hawk Biosciences, Inc. Transaction History

Sigma Planning Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$3.04 - $6.01 $30,573 - $60,442	-10,057 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$5.9 - $7.44 $8,260 - $10,416	-1,400 Reduced 12.22%	10,057 $60,000
Q2 2021 Aug 13, 2021	SELL	$5.78 - $9.6 $84,388 - $140,160	-14,600 Reduced 56.03%	11,457 $77,000
Q1 2021 May 06, 2021	BUY	$5.67 - $12.54 $147,743 - $326,754	26,057 New	26,057 $190,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.